ESC 365 - Clinical implications of low-to-intermediate trials for primary prevention of atherosclerotic CVD and risk stratification with N-terminal pro-B-type natriuretic peptide in the Rotterdam Study

EAPC Premium Access

Clinical implications of low-to-intermediate trials for primary prevention of atherosclerotic CVD and risk stratification with N-terminal pro-B-type natriuretic peptide in the Rotterdam Study

Session: Poster Session III - Saturday 08:30 - 12:30 - Epidemiology/ Public health_Part 1

Topic: Epidemiology, lipids

Speaker: Ms J. Pavlovic (Rotterdam, NL)

Event: EuroPrevent 2017

Congress Presentation

Add to my library

About the speaker

Ms Jelena Pavlovic

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

0 follower

15 more presentations in this session

Epidemiology/ Public health_Part 1 - Poster discussant:.

Changes in body weight and composition are associated with changes in left ventricular and atrial geometry in the general population

Differences in measured and self-reported anthropometric data: the Italian Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey 2008-2012

Speaker: Doctor L. Palmieri (Rome, IT)

Leisure time physical activity initiated by employer and its health effects. A 15-month follow-up study

Speaker: Doctor M. Skogstad (Oslo, NO)

Serum nitrite and nitrate levels, NOx, in cardiovascular mortality study

Speaker: Doctor A. Deev (Moscow, RU)

Access the full session

Poster Session III - Saturday 08:30 - 12:30 - Epidemiology/ Public health_Part 1

Speakers: Ms J. Pavlovic, Doctor L. Palmieri, Doctor M. Skogstad, Doctor A. Deev

About the event

EuroPrevent 2017

6 April - 8 April 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources